Given the multitude of global health concerns, it is crucial to promptly and precisely identify biomarkers like alpha-fetoprotein (AFP) in order to facilitate the early identification and treatment of diverse illnesses, with a special emphasis on cancer. Conventional detection techniques often exhibit limitations in terms of intricacy, temporal requirements, and ease of use, underscoring the pressing want for inventive resolutions. The use of electrochemical biosensors has shown great potential in the field of AFP detection, because they provide efficient, highly responsive, and economically viable detection capabilities. This study examines current advancements in electrochemical biosensors specifically designed for the detection of alpha-fetoprotein (AFP), with a focus on the incorporation of state-of-the-art materials, sophisticated manufacturing methods, and novel biorecognition approaches. This study seeks to meet the urgent need for dependable and easily available diagnostic tools in the worldwide battle against cancer and other illnesses by offering a thorough examination of the current advancements in electrochemical biosensors. By making progress in AFP detection technologies, our goal is to have a positive impact on healthcare outcomes, improve illness management, and eventually reduce the global burden of disease.